TY - JOUR
T1 - Digital Health Interventions to Enhance Tuberculosis Treatment Adherence
T2 - Scoping Review
AU - Lee, Sol
AU - Rajaguru, Vasuki
AU - Baek, Joon Sang
AU - Shin, Jaeyong
AU - Park, Youngmok
N1 - Publisher Copyright:
© 2023 JMIR Publications. All rights reserved.
PY - 2023/1
Y1 - 2023/1
N2 - Background: Digital health technologies are widely used for disease management, with their computing platforms, software, and sensors being used for health care. These technologies are developed to manage chronic diseases and infectious bacterial diseases, including tuberculosis (TB). Objective: This study aims to comprehensively review the literature on the use of digital health interventions (DHIs) for enhancing TB treatment adherence and identify major strategies for their adoption. Methods: We conducted a literature search in the PubMed, Cochrane Library, Ovid Embase, and Scopus databases for relevant studies published between January 2012 and March 2022. Studies that focused on web-based or mobile phone–based interventions, medication adherence, digital health, randomized controlled trials, digital interventions, or mobile health and ubiquitous health technology for TB treatment and related health outcomes were included. Results: We identified 27 relevant studies and classified them according to the intervention method, a significant difference in treatment success, and health outcomes. The following interventions were emphasized: SMS text messaging interventions (8/27, 30%), medicine reminders (6/27, 22%), and web-based direct observation therapy (9/27, 33%). Digital health technology significantly promoted disease management among individuals and health care professionals. However, only a few studies addressed 2-way communication therapies, such as interactive SMS text messaging and feedback systems. Conclusions: This scoping review classified studies on DHIs for patients with TB and demonstrated their potential for the self-management of TB. DHIs are still being developed, and evidence on the impact of digital technologies on enhancing TB treatment adherence remains limited. However, it is necessary to encourage patients’ participation in TB treatment and self-management through bidirectional communication. We emphasize the importance of developing a communication system.
AB - Background: Digital health technologies are widely used for disease management, with their computing platforms, software, and sensors being used for health care. These technologies are developed to manage chronic diseases and infectious bacterial diseases, including tuberculosis (TB). Objective: This study aims to comprehensively review the literature on the use of digital health interventions (DHIs) for enhancing TB treatment adherence and identify major strategies for their adoption. Methods: We conducted a literature search in the PubMed, Cochrane Library, Ovid Embase, and Scopus databases for relevant studies published between January 2012 and March 2022. Studies that focused on web-based or mobile phone–based interventions, medication adherence, digital health, randomized controlled trials, digital interventions, or mobile health and ubiquitous health technology for TB treatment and related health outcomes were included. Results: We identified 27 relevant studies and classified them according to the intervention method, a significant difference in treatment success, and health outcomes. The following interventions were emphasized: SMS text messaging interventions (8/27, 30%), medicine reminders (6/27, 22%), and web-based direct observation therapy (9/27, 33%). Digital health technology significantly promoted disease management among individuals and health care professionals. However, only a few studies addressed 2-way communication therapies, such as interactive SMS text messaging and feedback systems. Conclusions: This scoping review classified studies on DHIs for patients with TB and demonstrated their potential for the self-management of TB. DHIs are still being developed, and evidence on the impact of digital technologies on enhancing TB treatment adherence remains limited. However, it is necessary to encourage patients’ participation in TB treatment and self-management through bidirectional communication. We emphasize the importance of developing a communication system.
KW - PRISMA
KW - application
KW - chronic disease
KW - communication
KW - digital health
KW - disease management
KW - feedback
KW - medication
KW - medication adherence
KW - mobile apps
KW - patient compliance
KW - scoping review
KW - self-management
KW - text
KW - text messaging
KW - tuberculosis
UR - http://www.scopus.com/inward/record.url?scp=85178850701&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85178850701&partnerID=8YFLogxK
U2 - 10.2196/49741
DO - 10.2196/49741
M3 - Review article
C2 - 38054471
AN - SCOPUS:85178850701
SN - 2291-5222
VL - 11
JO - JMIR mHealth and uHealth
JF - JMIR mHealth and uHealth
IS - 1
M1 - e49741
ER -